Data is not available at this time.
Philip Morris International Inc. (PMI) is a global leader in the tobacco industry, strategically pivoting toward a smoke-free future. The company operates exclusively outside the U.S., offering a diversified portfolio that includes traditional cigarettes and innovative smoke-free products such as heat-not-burn devices (e.g., IQOS), vapor products, and oral nicotine alternatives. PMI’s flagship brands like Marlboro, Parliament, and HEETS dominate key markets, supported by extensive distribution networks and strong brand equity. The company’s transition toward reduced-risk products aligns with shifting regulatory and consumer trends, positioning it as a pioneer in harm reduction. PMI’s market leadership is reinforced by its investments in R&D and strategic partnerships, such as its licensing agreement with KT&G. With operations in 71 markets, PMI leverages its global scale to drive adoption of smoke-free alternatives, targeting long-term growth beyond traditional tobacco. Its multi-category approach mitigates reliance on cigarettes while capitalizing on premium pricing and innovation-led differentiation in a declining but still profitable industry.
PMI reported revenue of €37.9 billion in FY 2023, underpinned by a mix of cigarette sales and growing contributions from smoke-free products. Net income stood at €7.1 billion, reflecting robust margins despite industry headwinds. Operating cash flow of €12.2 billion highlights strong liquidity generation, while capital expenditures of €1.4 billion indicate disciplined reinvestment in next-generation products and supply chain optimization.
The company’s diluted EPS of €4.52 demonstrates sustained earnings power, driven by pricing strategies and cost efficiencies. PMI’s capital allocation prioritizes high-return investments in smoke-free platforms, with debt servicing balanced against shareholder returns. Its ability to maintain profitability amid declining cigarette volumes underscores pricing power and operational agility.
PMI’s balance sheet shows €4.2 billion in cash against €45.7 billion in total debt, reflecting leverage to fund acquisitions and innovation. The debt load is manageable given consistent cash flows, though interest coverage remains a focus area. Liquidity is adequate, with no near-term refinancing risks evident.
Smoke-free products now account for over 30% of PMI’s revenue, signaling successful diversification. The company offers a reliable dividend (€5.14 per share), supported by cash flow stability. Growth hinges on expanding reduced-risk product adoption, particularly in emerging markets where regulatory barriers are lower.
At a market cap of €243.5 billion, PMI trades at a premium to peers, reflecting its transition progress and smoke-free leadership. Investors price in long-term margin expansion as high-margin alternatives offset cigarette declines. The low beta (0.52) suggests defensive appeal amid economic uncertainty.
PMI’s first-mover advantage in smoke-free technology and global distribution network provide durable competitive edges. Regulatory risks persist, but the company’s proactive stance on harm reduction and portfolio diversification positions it for sustainable growth. Near-term challenges include geopolitical volatility and inflation, but PMI’s pricing power and innovation pipeline underpin resilience.
Company filings, investor presentations, Bloomberg
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |